National Health (Pharmaceutical Benefits) Regulations (Amendment)

Overview

The Statutory Rules 1976 No. 195, made under the National Health Act 1953, aim to address gaps in the regulatory framework governing pharmaceutical benefits in Australia. Enacted by the Governor-General of the Commonwealth of Australia on the advice of the Federal Executive Council, these regulations serve to refine and update the existing legislative provisions. The primary objective is to ensure clarity and consistency in the administration of pharmaceutical benefits by updating definitions and allowing for appropriate charges in specific circumstances. This legislative instrument seeks to maintain the integrity of the pharmaceutical benefits scheme while adapting to evolving healthcare needs.

Scope and Application

The Statutory Rules 1976 No. 195, made under the National Health Act 1953, amend the National Health (Pharmaceutical Benefits) Regulations, impacting approved pharmaceutical chemists. These Regulations apply to individuals who are approved pharmaceutical chemists and are deemed to be approved under section 90 of the Act. The regulations govern the charges that approved pharmaceutical chemists can impose when supplying pharmaceutical benefits outside normal trading hours. Specifically, these amendments define an "approved pharmaceutical chemist" and establish a cap on the charges that can be made for pharmaceutical supplies provided outside standard business hours. The regulations' scope is national, applying across the Commonwealth of Australia, and they directly affect the pharmaceutical industry and the conduct of approved chemists. There are no stated exclusions or exemptions in these specific regulations, and they do not extend their application through subordinate instruments but rather directly amend the existing regulations.

Key Provisions

The Statutory Rules 1976 No. 195, made under the National Health Act 1953, introduce amendments to the National Health (Pharmaceutical Benefits) Regulations. The primary changes include the repeal of certain regulations and the insertion of new definitions and provisions. For instance, regulation 3 is repealed entirely, removing any previous provisions that may have been in place under this section (1). Additionally, regulation 5 is amended by adding a new definition for "approved pharmaceutical chemist" (2), which specifies that such a chemist must be approved or deemed to be approved under section 90 of the Act. These regulations impose several obligations and requirements on the parties involved, particularly on approved pharmaceutical chemists. One significant requirement is that an approved pharmaceutical chemist may charge a fee when supplying pharmaceutical benefits outside normal trading hours (3). This fee is limited to a maximum of $2 for a single pharmaceutical benefit supplied, or an amount calculated by dividing $2 by the number of pharmaceutical benefits if more than one is supplied. Furthermore, the regulations outline potential consequences for breaches, although the specific legal penalties or civil/criminal consequences are not detailed within the text of these regulations. Typically, breaches of regulations made under the National Health Act 1953 could result in penalties as prescribed by the Act itself or other relevant legislation. Such penalties might include fines, corrective actions, or other administrative measures to ensure compliance with the health and pharmaceutical benefit provisions outlined in the Act.